161
Participants
Start Date
December 31, 1999
Primary Completion Date
June 30, 2001
Study Completion Date
June 30, 2001
Gemcabene 150 mg
Blinded capsules and tablets, 150 mg, once daily, 84 days
Gemcabene 300 mg
Blinded capsules and tablets, 300 mg, once daily, 84 days
Gemcabene 600 mg
Blinded capsules and tablets, 600 mg, once daily, 84 days
Gemcabene 900 mg
Blinded capsules and tablets, 900 mg, once daily, 84 days
Placebo
Blinded capsule and tablets, once daily, 84 days
Lead Sponsor
NeuroBo Pharmaceuticals Inc.
INDUSTRY